Pharma's Almanac TV
PA TV
Your Name
Your Email
Manage Account
Sign Out
Sign In
Register
Follow the Journey
Companies On The Road
Arcadis DPS Group
C2 Pharma
CAI
EcoLab
Environmental Systems Corporation
Federal Equipment Company
Globyz Biopharma Services
Grifols
Integrity
Nu-Tek BioSciences
PHARMALEX
Waters Corporation
Follow the Journey
Companies On The Road
ABS
aCGT Vector
Alconox Inc.
Andelyn Biosciences
Arranta Bio
Avid Bioservices
BDD
BIOVECTRA
DPS Group
Dynamk Capital
Environmental Systems Corporation
Federal Equipment Company
Genesis AEC
Globyz Biopharma Services
Grifols Partnership
IDT Biologika
Inceptor Bio
IPS-Integrated Project Services
Kineticos Life Sciences
MilliporeSigma
Montana BioScience Alliance
Olon
Rentschler Biopharma
SanaClis
Scorpion Biological Services
Secant Group
Tapemark
VITRONIC
Follow the Journey
Companies On The Road
AES Clean Technology
Altis Biosystems
Arranta Bio
Avara Pharmaceutical Services
Avid Bioservices
BioVectra
Centaur BPS
Dynamk Capital
ECRI
Evolve Biologics
Federal Equipment Company
Globyz
Inceptor Bio
IPS-Integrated Project Services
Olon
Pii
Polpharma Biologics
PPD
RoosterBio
SanaClis
Sanofi AIS
SGD Pharma
SPI Pharma
TriRx Pharmaceutical Services
Yourway
Dashboard
Topics
Products
ADC
API - Small Molecule
Biologics
Biopharmaceuticals
Biosimilars
Cell and Gene Therapy
DNA
Drug Product
Drug Substance
Equipment
Generics
Immunotherapy
Injectables
Monoclonal Antibody
Novel Therapeutics
Oral Solid Dosage
Orphan Drugs
Parenterals
Stem Cells
Vaccine
Services
Big Data
Bioprocessing
Clinical Trials
Continuous Manufacturing
Diagnostics
Drug Delivery
Drug Development
Drug Discovery
Facility
Formulation
Innovation
Oncology
Patient Adherence
Patient Centric
Preclinical
Process Development
Quality
Regulatory
Research
Serialization
Segment
Biomanufacturing
Biotechnology
CDMO
Consulting
CRO
Engineering
Equipment
Excipients
Healthcare
Intermediates
Logistics
Manufacturing
Packaging
Supply Chain
Business
Agreement
Appointment
Business
Capacity Expansion
Collaboration
Growth
Investment
Licensing
M&A
Market Expansion
Market Intelligence
Market Prediction
New Facility
Strategic Partnership
Magazine
Archive
Reports
Nice Insight Reports
2022 Sterile
2023 Cell & Gene Therapy
2023 mAb and Recombinant Protein
2024 API
2024 OSD
2024 ADC
2024 mRNA
2024 Mammalian Cell Culture
2024 Microbial Cell Culture
2024 Plasmids
2024 Gene Therapy
2024 Cell Therapy
2024 Sterile
Community
Company A to Z
Follow the Journey
Companies On The Road
Follow The Artist
Follow the Journey
Companies On The Road
More+
Staffing
Media Kit
Biotech
51 Articles Available
1
3
Can't find what you're looking for? Try our
advanced search
.
Nice Insight Reports
Biotech Funding Ups and Downs
PAO-04-24-NI-01
Partnerships
Alloy Therapeutics and Wheeler Bio Announce Preferred Service Offering for Alloy Partners to Accelerate the Translation from Discovery to CMC
PR-M11-23-01
New Facility
Wheeler Bio Announces Grand Opening of Biomanufacturing Facility
PR-M10-23-01
Immuno-Oncology
Targeted Immune System Activation: A Paradigm Shift in Immuno-oncology
PAO-12-022-CL-01
Synthetic Biology
Synthetic Biology: A Potential Game-Changer for the Biopharma Industry
PAO-12-022-NI-01
Digital Therapeutics
Digital Therapeutics and the Song of the Future of Healthcare
PAO-12-022-CL-02
Hemostatic
Stopping Bleeds and Saving Lives
PAO-11-022-CL-09
Plant-Inspired Drug Discovery
Unlocking the Therapeutic Potential of Plant-Inspired Minimum Essential Mixtures
PAO-08-022-CL-01
Life Science Industrials
Life Science Industrials Are Key to the Growth of the Biopharma Industry
PAO-07-022-CL-05
New Division
Olon Presents Olon Biotech, A New Division Operating by Biotechnological Processes
PR-M07-22-03
Column: Investment
IPOs Have Not Recovered In 2022. When Will Biotech Bounce Back?
PAO-06-022--NI-02
Biotechs
10 More Biotechs Making Moves in 2022
PAO-06-022--NI-07
CRO
Crafting a Successful Partnership with a Contract Research Organization
PAO-06-022-CL-05
Enabling Drug Discovery Targeting Ion Channels
Ion Channels
Global License Agreement
Hovione and JIXING Announce an Exclusive Global License Agreement for Ophthalmology Program
PR-M05-22-04
Investment
Bringing Value to Pharma and Biopharma
PAO-04-22-R250-75
CRISPR Clinical Trial
SNIPR BIOME Initiates First-in-Human Clinical Trial with SNIPR001
PR-M04-22-11
Artificial Intelligence
Bringing Artificial Intelligence to Biopharma
PAO-04-22-R250-07
Arizona Bioscience
Biotechnology Growth in Arizona
PAO-04-22-R250-04
Phase I Trial
Anixa Biosciences Announces the Initiation of its Ovarian Cancer CAR-T Phase I Trial at Moffitt Cancer Center
PR-M03-22-17
Column: Investment
2021 Was a Great Year for Biotech IPOs, Depending on When You Got Out
PAO-03-022-NI-07
Biotechs
10 Promising Biotechs Aiming to Transform Medicine
Cell Culture
Changing the Future of Cell Culture and Accelerating Next-Generation Therapies
PAO-02-022-CL-20
Neurodegenerative Diseases
Pioneering Nanocatalysis to Revolutionize Treatments for Neurodegenerative Diseases
PAO-01-22-CL-06
1
3
»